Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Anjian Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). Based in Xi'an, the company focuses primarily on anti-infective therapeutics, including a range of cephalosporin and macrolide antibiotics. Its production facilities are GMP-certified, enabling the manufacture of various oral dosage forms such as dispersible tablets and capsules. Xi'an Anjian is recognized as a high-tech enterprise in Shaanxi Province and serves the domestic healthcare market with high-quality generic medications. The company emphasizes clinical efficacy and safety in its product portfolio, which includes well-known treatments like Cefixime and Azithromycin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Anjian Pharmaceutical.